First-time test-takers in Jefferson’s College of Pharmacy (JCP) Class of 2024 finished in the top 8% of the nation for the North American Pharmacist Licensure Examination (NAPLEX).
Out of 143 participating schools, JCP’s Class of 2024 scored the highest among Pennsylvania, New England and Mid-Atlantic programs, says Dr. Mary Hess, JCP interim dean. More than half of participating schools’ scores were below 80%, while JCP’s was over 90%.
Two examinations are required to practice as a licensed pharmacist: one that evaluates general practice knowledge (NAPLEX) and another that focuses on pharmacy law, the Multistate Pharmacy Jurisprudence Examination (MPJE). The Class of 2024’s MPJE first-time test-taker score was 86.1% vs. the national rate of 76.6%.
Historically, JCP has had an excellent first-time pass rate on board exams, with rates in the mid-90% range, including three classes achieving a 100% pass rate, says Dr. Hess, noting the Class of 2024 faced the challenge of completing a portion of their studies during the pandemic. To ensure success, JCP conducted additional reviews to assess potential preparation gaps.